Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome.

British journal of cancer - 10 Mar 2009

Umemura S, Shirane M, Takekoshi S, Kusakabe T, Itoh J, Egashira N, Tokuda Y, Mori K, Osamura Y R

Abstract excerpt

The purpose of the present study is to identify genes that contribute to cell proliferation or differentiation of breast cancers independent of signalling through the oestrogen receptor (ER) or human epidermal growth factor receptor 2 (HER2). An oligonucleotide microarray assayed 40 tumour sample...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Cytogenetic Analysis
Share to Cytoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor alpha

Share to Gene Amplification

Share to Receptor, ErbB-2

Share to Tissue Distribution

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 19259095
DOI: 10.1038/sj.bjc.6604900
PMCID: PMC2653774

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19259095-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome.PMID 19259095Read ↗

Kru¨ ppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgensSemantic proximity Read ↗

E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancerSemantic proximity Read ↗

ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.Semantic proximity Read ↗

ELF5: A Molecular Clock for Breast Aging and Cancer SusceptibilitySemantic proximity Read ↗

Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell ProliferationSemantic proximity Read ↗

HumanE2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumorsSemantic proximity Read ↗

ELF5 inhibits migration and invasion of breast cancer cells via regulating CD24 expressionSemantic proximity Read ↗

An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.Semantic proximity Read ↗

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.Semantic proximity Read ↗

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Semantic proximity Read ↗

Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.Semantic proximity Read ↗

Increased Expression of the E3 Ubiquitin Ligase RNF5 Is Associated with Decreased Survival in Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.